EQ Wealth Advisors’s Instil Bio TIL Stock Holding History

EQ Wealth Advisors’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40	Closed	-$440	–	216
2025 Q4	$440	Buy	+40	New	+$592	﹤0.01%	245
2025 Q3	–	Sell	-40	Closed	-$833	–	208
2025 Q2	$833	Hold	40	–	–	﹤0.01%	218
2025 Q1	$694	Buy	+40	New	+$830	﹤0.01%	237

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

EQ Wealth Advisors's TIL Position: Q1 2026 in Review

EQ Wealth Advisors sold out of Instil Bio (TIL) in Q1 2026, closing a stake of 40 shares — an estimated $440 sold.

EQ Wealth Advisors first reported a position in TIL in Q1 2025 and held it in 3 quarters. The position peaked at $833 in Q2 2025. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

EQ Wealth Advisors reported no remaining Instil Bio position as of Q1 2026 after selling out during the quarter.
EQ Wealth Advisors sold 40 Instil Bio shares in Q1 2026, an estimated $440.
EQ Wealth Advisors first reported a position in Instil Bio in Q1 2025 and held it in 3 quarters.
EQ Wealth Advisors's Instil Bio position peaked at $833 in Q2 2025.
32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on EQ Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.